Search This Site!
Skip to Page Content
ISN Profiles
ALPHABETICAL BY TEAMS
How to Volunteer
Active Volunteers (Main List)
Enrolling or Rep Form
Inactive Volunteers
On Leave, Update, Retired
Board of Directors
Development/Fundraising
Medical Advisory Board
Newsroom Team
Publishing
Support
Translations
Website
Volunteer Services
Ways You Can Help
Dr. Janet Pope, MD
ISN Medical Advisory Board
I am a rheumatologist in Canada with a specific interest in scleroderma.

Dr. Janet PopeHello, my name is Janet Pope and I am a rheumatologist in Canada with a specific interest in scleroderma, especially clinical trials and clinical research studies. I am an Associate Professor of the Department of Medicine, Division of Rheumatology and Epidemiology and Biostatistics at the University of Western Ontario, London, Ontario, Canada.

I obtained my MD and Fellowship in Internal Medicine at the University of Western Ontario. I acquired a Fellowship in Rheumatology and Masters of Public Health at Boston University. I completed a Canadian Arthritis Society Research Fellowship In London, Ontario in scleroderma, and then became a member of the Division of Rheumatology. I am currently Program Director in Rheumatology, sit on five Advisory Boards, and am member of the Scleroderma Clinical Trials Consortium.

I have published over fifty research articles pertaining to rheumatic diseases. I look forward to sharing my expertise in this field. My email address is janet-pope@sclero.org.

Related Links
ISN Medical Advisory Board
Dr. James R. Seibold, Chair
Dr. Luis Catoggio, Argentina
Dr. C. Stephen Foster, U.S.
Dr. Hsiao-Yi Lin, Taiwan
Dr. Tafazzul Mahmud, Pakistan
Dr. Matucci-Cerinic, Italy
Dr. Janet Pope, Canada
Dr. Shinichi Sato, Japan
Dr. James Seibold, Chair
Dr. van den Hoogen, Netherlands
Prevalence of Elevated Pulmonary Arterial Pressures Measured by Echocardiography in a Multicenter Study of Patients with Systemic Sclerosis. Elevated pulmonary arterial pressures (PAP) are common in both limited and diffuse SSc disease, occurring in 21% of limited and 26% of diffuse SSc patients. A high index of suspicion is important and routine echocardiography in symptomatic patients may allow earlier diagnosis of PAH and intervention. J Rheumatol. 2005 July;32:1273-8. (Also see: Pulmonary Hypertension, Limited Scleroderma, and Diffuse Scleroderma)
Dr. Janet Pope: The University of Western Ontario
Kym: Diffuse, CREST Scleroderma, Lupus and Fibromyalgia It all started with Raynaud's in my fingers and toes when I was about nineteen years old, in 1979...
Scleroderma Treatment Differs Among Experts vs. General Rheumatologists. Scleroderma experts see more SSc patients and use more immuno-suppressives including unproven treatments. They also use less drugs where a negative trial exists (ie.as with D-pen) than other rheumatologists. SCTC may treat more severe cases, but it also may be that ILD and PAH are under-recognized by non-experts. J. E. Pope, J. Ouimet, A. Krizova. The University of Western Ontario, London, ON, Canada.
Scleroderma Care and Research JournalScleroderma Care and Research Journal: Spring 2004. This free online PDF medical journal issue includes articles on Diagnostic and Management Preferences for Lung Disease in Scleroderma, and Erectile Dysfunction in Men with Scleroderma. SCTC 6-2-04. (Also see: Lung Involvement and Sexuality and Scleroderma)
Scleroderma Treatment Differs Among Experts vs. General Rheumatologists. Scleroderma experts see more SSc patients and use more immunosuppressives including unproven treatments. They also use less drugs where a negative trial exists (ie.as with D-pen) than other rheumatologists. There are some differences in the treatment of SSc between Canada, the US and the SCTC, perhaps due to the lack of guidelines and proven interventions. SCTC may treat more severe cases, but it also may be that ILD (interstitial lung disease) and PAH (pulmonary arterial hypertension) are under-recognized by non-experts. J. E. Pope. ACR Conference Oct. 2003 (Also see: Scleroderma Specialists, Pulmonary Fibrosis, and Pulmonary Hypertension)
Keep on Surfing!
Go to Roland, Pamela
Since 1998, we have complied with the HONcode standard for health trustworthy information: verify here. The International Scleroderma Network (SCLERO.ORG) is a full-service nonprofit. Check our nonprofit status with Guidestar.org Please let us know how we can help you.
Warm Hugs,
Shelley Ensz, ISN Founder & President
Contact ISN
Inquiry Form (English) Mail-In Donation/Order Form Online Donation/Order Form
Inquiry Form (Spanish) Website: www.sclero.org Please contact us in English.
Email: isn@sclero.org or
webmaster@sclero.org
Or post a message in our Sclero Forums!
International Scleroderma Network
7455 France Ave So #266
Edina, MN 55435-4702 USA
Toll Free Hotline in U.S.
1-800-564-7099
Direct Line 952-831-3091 (U.S.)
The most important thing in the world to know about scleroderma is sclero.org!
© Copyright 1998-2008 International Scleroderma Network
All Rights Reserved